Blog
T1International Statement on Pharma’s Attempt to Block Minnesota’s Insulin Bill
1 Jul 2020, 8:58 p.m. in News & Statements by T1International
T1International is outraged, though not surprised, to see pharmaceutical companies once again put profit over human lives. On Tuesday, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against the state of Minnesota to challenge the Alec Smith Insulin Affordability Act. Read more
An Insulin Resolution is Necessary for Lebanon and the World
29 Jun 2020, 9:30 a.m. in Global Stories by Cyrine Farhat
Lebanon’s recent financial crisis has caused a dollar shortage that, since September, has restricted the ability of medical supply importers to import vital medical supplies. First it started with masks, gloves, and other protective gear, as well as ventilators and spare parts, and now even essential diabetes supplies are sometimes unavailable. Read more
T1International Statement on World Health Assembly Insulin Resolution Meeting
19 Jun 2020, 10:38 a.m. in News & Statements by T1International
We were proud that Cyrine Farhat of Lebanon represented T1International, the #insulin4all movement and people living with type 1 diabetes as one of six speakers at a collaborative virtual event about a WHA Resolution on Access to Insulin. Read more
My Black Diabetic Life Matters
15 Jun 2020, 9:36 a.m. in #insulin4all USA, Global Stories by Anonymous
When I left the hospital I remember wondering, “Why did my mom have to beg those people to do their job when I was visibly sick?” A few years later after I had dealt with numerous visits, checkups, and insurance calls, I became aware of the medical side of racism. Read more
Utahns Welcome Passage of Insulin Access Amendments
27 May 2020, 1:18 p.m. in #insulin4all USA by Mindie Hooley
After many emotional months of fighting hard for accessible and affordable insulin legislation, Utah won a victory March 30, 2020 when House Bill 207, known as the Insulin Access Amendments, was signed into law by Governor Gary Herbert. This victory was thanks in part to the strong advocacy of thousands of Utahns and to Representative Norman Thurston’s dedicated leadership on drafting lifesaving legislation. This legislation passed with strong bipartisan support through the House with a 69-3 vote and passed unanimously in the Senate. Read more
Launch of U.S. State Legislative Guide for Insulin for All
14 May 2020, 10:41 a.m. in #insulin4all USA by T1International
T1International is pleased to introduce a new advocacy resource, the U.S. Legislative Guide for insulin for all: How States Can Make Medicines Affordable. The resource, developed in partnership with Public Citizen, outlines a variety of legislation that could help to make insulin more accessible and affordable. Read more
How Shareholders Benefit from Insulin Price Increases
6 May 2020, 11:11 a.m. in #insulin4all USA, Global Stories by Rosie Collington
In March of this year, researchers at the University of Pittsburgh provided evidence that the net price of insulin medicines in the United States had also soared – by 51% between 2008-2017. This indicates that while other intermediaries had benefited from list price increases, the manufacturers had too. This may seem obvious, but having data to prove it is important. Read more
Advocates Celebrate Passage of Alec Smith Bill in Minnesota
15 Apr 2020, 8:26 p.m. in #insulin4all USA by T1International
After months of diligent advocacy, partisan gridlock, and intense negotiations, the Alec Smith Emergency Insulin Bill was signed into law today in Minnesota. Alec’s Bill is named for 26-year-old Alec Smith, who passed away after rationing his insulin in 2017. The legislation, which is the first of its kind in the nation, establishes a program for patients with diabetes to purchase the insulin they need at an affordable price. To get to this moment, advocates in Minnesota endured a tough - and long - fight. Read more
Global Type 1 Diabetes Coronavirus Perspectives
10 Apr 2020, 10:41 a.m. in Global Stories by T1International
Ten people living with type 1 diabetes share their perspectives about the impact of the coronavirus on their country and their health. Read more
T1International Statement on Insulin Manufacturer's Responses to COVID-19
7 Apr 2020, 5:29 p.m. in #insulin4all USA, News & Statements by T1International
The best way for insulin manufacturers to demonstrate their commitment to patient health would be for them to permanently lower their list price, which would make low-cost insulin easier to acquire and apply to every patient who needs it. Read more